Asian Diabetes Outcomes Prevention Trial

Conditions:   Diabetes Mellitus;   Cardiovascular Diseases Interventions:   Drug: Renin-angiotensin-aldosterone system inhibitors;   Drug: Beta blocker;   Drug: SGLT2 Inhibitor - Sodium Glucose Cotransporter Subtype 2 Inhibitor Product Sponsors:   National Heart Centre Singapore;   Singapore General Hospital;   Mackay Memorial Hospital;   National Taiwan University Hospital;   Peking University People's Hospital;   Medanta, The Medicity, India;   Public Health Foundation of India;   Putrajaya Hospital, Malaysi a;   Universiti Teknologi Mara Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials